Showing 1 - 6 results of 6 for search 'Bertolino, A', query time: 0.02s
Refine Results
-
1
CONNECT Challenges: Towards Emergent Connectors for Eternal Networked Systems by Issarny, V, Steffen, B, Jonsson, B, Blair, G, Grace, P, Kwiatowska, M, Calinescu, R, Inverardi, P, Tivoli, M, Bertolino, A, Sabetta, A
Published 2009Conference item -
2
EVALUATION OF EFFICACY AND SAFETY OF SECUKINUMAB IN THE TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE ANKYLOSING SPONDYLITIS by Emery, P, Baeten, D, Sieper, J, Braun, J, van der Heijde, D, McInnes, I, Van Laar, J, Landewe, R, Wordsworth, B, Wollenhaupt, J, Kellner, H, Paramarta, I, Bertolino, A, Wright, A, Hueber, W
Published 2012Conference item -
3
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. by Hueber, W, Sands, B, Lewitzky, S, Vandemeulebroecke, M, Reinisch, W, Higgins, P, Wehkamp, J, Feagan, BG, Yao, MD, Karczewski, M, Karczewski, J, Pezous, N, Bek, S, Bruin, G, Mellgard, B, Berger, C, Londei, M, Bertolino, A, Tougas, G, Travis, S
Published 2012Journal article -
4
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: Unexpected results of a randomised, double-blindplacebo- controlled trial by Hueber, W, Sands, B, Lewitzky, S, Vandemeulebroecke, M, Reinisch, W, Higgins, P, Wehkamp, J, Feagan, BG, Yao, MD, Karczewski, M, Karczewski, J, Pezous, N, Bek, S, Bruin, G, Mellgard, B, Berger, C, Londei, M, Bertolino, A, Tougas, G, Travis, S
Published 2012Journal article -
5
Improvement in Signs and Symptoms of Active Ankylosing Spondylitis Following Treatment with Anti-Interleukin (IL)-17A Monoclonal Antibody Secukinumab Are Paralleled by Reductions i... by Baeten, D, Bek, S, Wei, J, Brachat, A, Sieper, J, Emery, P, Braun, J, van der Heijde, D, McInnes, I, van Laar, J, Landewe, R, Wordsworth, P, Wollenhaupt, J, Kellner, H, Paramarta, J, Bertolino, A, Wright, A, Wolfgang, H
Published 2012Conference item -
6
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. by Baeten, D, Baraliakos, X, Braun, J, Sieper, J, Emery, P, van der Heijde, D, McInnes, I, van Laar, J, Landewé, R, Wordsworth, P, Wollenhaupt, J, Kellner, H, Paramarta, J, Wei, J, Brachat, A, Bek, S, Laurent, D, Li, Y, Wang, Y, Bertolino, A, Gsteiger, S, Wright, A, Hueber, W
Published 2013Journal article